Skip to main content
Clinical Trials/NCT01984944
NCT01984944
Completed
N/A

Characterisation of Circadian Rhythm in Autistic Spectrum Disorder : a Clinical, Biochemical and Genetic Study

Assistance Publique - Hôpitaux de Paris1 site in 1 country42 target enrollmentOctober 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Autistic Disorder
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
42
Locations
1
Primary Endpoint
Urinary sulfatoxymelatonin secretion
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Autism spectrum disorders (ASDs) are complex neurodevelopmental conditions characterized by deficits in social communication, delay in language and repetitive behaviors. Results from genetic studies reveal one pathway associated with susceptibility to ASDs, which includes synaptic cell adhesion molecules. Among the factors that could modulate this pathway are the genes controlling circadian rhythms. Sleep disorders and low melatonin levels are frequently observed in ASDs. Thus investigator will characterize the circadian rhythms of patients with ASD and search for circadian rhythms genes polymorphisms.

Registry
clinicaltrials.gov
Start Date
October 2009
End Date
August 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with autistic spectrum disorders
  • At least 6 years old
  • Membership of a social security scheme
  • Informed consent signed by the patient or both holders of parental authority if the subject is a minor, or by a guardian if the subject is under guardianship

Exclusion Criteria

  • Recent sleep symptoms
  • Incapacity to keep rested for 24 hours

Outcomes

Primary Outcomes

Urinary sulfatoxymelatonin secretion

Time Frame: The determination will be performed at 21 days ( adults)

Secondary Outcomes

  • Core body temperature rhythm(The determination will be performed at 5 days (adult))
  • Circadian rhythms assessed with actometer(The determination will be performed at 14 ( child) and 21 days (adult))

Study Sites (1)

Loading locations...

Similar Trials